NRG 200 Pharmacology for Human Caring Nursing - Final
Exam Prep Document | 2026/2027 Edition | 200 Verified
Questions - 160 Questions with Answers
NRG 200 Pharmacology for Human Caring Nursing Final Exam 2026-160 QUESTIONS AND ANSWERS
ALREADY GRADED A+. 100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document is meticulously crafted for nursing students enrolled
in NRG 200 Pharmacology for Human Caring Nursing. It contains 200 verified multiple-choice
questions with correct answers and detailed explanations in italics, covering the entire curriculum.
Designed to reflect the latest 2026/2027 academic guidelines, this resource ensures a thorough
understanding of pharmacological principles within the context of human caring. It is an essential tool
for achieving a top grade on the final exam.
Key Features:
Foundations of Pharmacology: Drug classifications, pharmacokinetics, pharmacodynamics, and the nursing
process in medication administration.
Human Caring in Pharmacology: Integration of caring theories, patient-centered care, and ethical/legal
considerations in pharmacotherapy.
Autonomic Nervous System Drugs: Adrenergic agonists/antagonists, cholinergic agonists/antagonists, and their
clinical applications.
Cardiovascular Pharmacology: Drugs for hypertension, heart failure, angina, arrhythmias, and hyperlipidemia.
Respiratory Pharmacology: Bronchodilators, corticosteroids, antihistamines, and decongestants.
Endocrine Pharmacology: Insulin, oral hypoglycemics, thyroid medications, and corticosteroids.
Neurological and Psychiatric Pharmacology: Antiepileptics, antiparkinson agents, antidepressants,
antipsychotics, and anxiolytics.
Analgesics and Anti-inflammatory Agents: Opioids, NSAIDs, acetaminophen, and adjuvant analgesics.
Antimicrobial Pharmacology: Antibiotics, antivirals, antifungals, and antiparasitics, including resistance and
stewardship.
Chemotherapy and Immunomodulators: Antineoplastic agents, immunosuppressants, and biologic response
modifiers.
Fluid, Electrolyte, and Acid-Base Balance: IV fluids, diuretics, and electrolyte replacements.
Special Populations: Pediatric, geriatric, pregnancy/lactation considerations, and pharmacogenomics.
Updates for 2026:
- Revised to align with the 2026/2027 National Council Licensure Examination (NCLEX) test plan.
- Integrated current evidence-based practice guidelines from the American Nurses Association and specialty
organizations.
- Enhanced rationales to include critical thinking and clinical judgment cues.
- Updated drug information to reflect the latest FDA approvals and safety alerts.
- Expanded coverage of human caring frameworks in pharmacology, including Jean Watson's Theory of Human
Caring.
Abstract:
This exam preparation document for NRG 200 Pharmacology for Human Caring Nursing provides a rigorous and
comprehensive review of pharmacological principles as applied to nursing practice. It encompasses the
foundational concepts of drug therapy, including pharmacokinetics and pharmacodynamics, while emphasizing the
integration of human caring values in medication administration. The document systematically addresses major
Page 1
,drug classifications affecting the autonomic nervous system, cardiovascular, respiratory, endocrine, neurological,
and psychiatric systems, as well as analgesics, antimicrobials, chemotherapeutic agents, and fluid/electrolyte
balance. Special attention is given to vulnerable populations and the ethical-legal dimensions of pharmacotherapy.
Each of the 200 multiple-choice questions is accompanied by a correct answer and an italicized explanation that
reinforces the underlying science and clinical reasoning. This resource is designed to foster deep learning, critical
thinking, and readiness for the final examination, ultimately promoting safe and compassionate patient care.
Keywords:
Pharmacology, Human Caring, Nursing, NCLEX, Drug classifications, Pharmacokinetics, Patient-centered care,
Exam prep
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is clearly indicated,
and an explanation in italics follows, detailing the pharmacological rationale, nursing implications, and why the
other options are incorrect. This format enhances understanding and retention of key concepts.
Compliance Checklist:
Aligned with 2026/2027 NRG 200 course objectives and syllabus
Reflects the latest NCLEX-RN test plan and nursing standards
Includes 200 verified questions with accurate answers and evidence-based rationales
Covers all major content areas and drug classifications as per the curriculum
Suitable for self-assessment and comprehensive exam review
Content Area Overview:
Content Area Questions Key Topics Weight
Foundations of Pharmacology 1-20 Drug classifications, Pharmacokinetics, 10%
Pharmacodynamics, Nursing process
Human Caring in Pharmacology 21-30 Caring theories, Patient-centered care, 5%
Ethical/legal issues
Autonomic Nervous System 31-50 Adrenergic agonists/antagonists, Cholinergic 10%
Drugs agonists/antagonists
Cardiovascular Pharmacology 51-70 Antihypertensives, Heart failure drugs, 10%
Antiarrhythmics, Antianginals,
Lipid-lowering agents
Respiratory Pharmacology 71-85 Bronchodilators, Corticosteroids, 7.5%
Antihistamines, Decongestants
Endocrine Pharmacology 86-100 Insulin, Oral hypoglycemics, Thyroid 7.5%
medications, Corticosteroids
Neurological and Psychiatric 101-120 Antiepileptics, Antiparkinson agents, 10%
Pharmacology Antidepressants, Antipsychotics,
Anxiolytics
Analgesics and 121-135 Opioids, NSAIDs, Acetaminophen, 7.5%
Anti-inflammatory Agents Adjuvant analgesics
Antimicrobial Pharmacology 136-155 Antibiotics, Antivirals, Antifungals, 10%
Antiparasitics, Antimicrobial stewardship
Chemotherapy and 156-170 Antineoplastic agents, Immunosuppressants, 7.5%
Immunomodulators Biologic response modifiers
Page 2
,Fluid, Electrolyte, and 171-185 IV fluids, Diuretics, Electrolyte 7.5%
Acid-Base Balance replacements
Special Populations 186-200 Pediatric, Geriatric, Pregnancy/lactation, 7.5%
Pharmacogenomics
Page 3
, Q1. A patient with chronic kidney disease (CrCl 25 mL/min) is prescribed a
medication that is primarily excreted unchanged by the kidneys. The nurse is aware
that the half-life of this drug will be prolonged. Which pharmacokinetic parameter is
most directly affected by this renal impairment?
A. Volume of distribution
B. Clearance
C. Bioavailability
D. First-pass effect
Correct Answer: B. Clearance
Rationale: Renal impairment reduces drug clearance, leading to a prolonged half-life and
potential accumulation. Volume of distribution depends on tissue binding and body
composition, not directly on renal function. Bioavailability and first-pass effect are related
to absorption and hepatic metabolism, not renal excretion.
Why Wrong:
A - Volume of distribution is more affected by changes in body composition or protein
binding, not renal function.
C - Bioavailability is a measure of the fraction of drug that reaches systemic
circulation, influenced by absorption and hepatic metabolism.
D - First-pass effect is a hepatic phenomenon, not directly linked to renal excretion.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 4.
Q2. A nurse is caring for a patient who is taking digoxin and furosemide. The patient
reports nausea, vomiting, and visual disturbances. Which laboratory value would be
most indicative of digoxin toxicity in this context?
A. Serum potassium of 3.0 mEq/L
B. Serum magnesium of 2.0 mEq/L
C. Serum digoxin level of 0.8 ng/mL
D. Serum creatinine of 1.0 mg/dL
Correct Answer: A. Serum potassium of 3.0 mEq/L
Rationale: Hypokalemia (K+ < 3.5 mEq/L) potentiates digoxin toxicity by increasing the
binding of digoxin to Na+/K+-ATPase. Typical symptoms include GI disturbances and
visual changes. Magnesium of 2.0 mEq/L is normal, digoxin level of 0.8 is therapeutic, and
creatinine of 1.0 is normal.
Why Wrong:
B - Normal magnesium levels do not precipitate digoxin toxicity.
C - A digoxin level of 0.8 ng/mL is within the therapeutic range (0.5-2.0 ng/mL).
D - Normal renal function does not directly cause digoxin toxicity.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 30.
Page 4
Exam Prep Document | 2026/2027 Edition | 200 Verified
Questions - 160 Questions with Answers
NRG 200 Pharmacology for Human Caring Nursing Final Exam 2026-160 QUESTIONS AND ANSWERS
ALREADY GRADED A+. 100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document is meticulously crafted for nursing students enrolled
in NRG 200 Pharmacology for Human Caring Nursing. It contains 200 verified multiple-choice
questions with correct answers and detailed explanations in italics, covering the entire curriculum.
Designed to reflect the latest 2026/2027 academic guidelines, this resource ensures a thorough
understanding of pharmacological principles within the context of human caring. It is an essential tool
for achieving a top grade on the final exam.
Key Features:
Foundations of Pharmacology: Drug classifications, pharmacokinetics, pharmacodynamics, and the nursing
process in medication administration.
Human Caring in Pharmacology: Integration of caring theories, patient-centered care, and ethical/legal
considerations in pharmacotherapy.
Autonomic Nervous System Drugs: Adrenergic agonists/antagonists, cholinergic agonists/antagonists, and their
clinical applications.
Cardiovascular Pharmacology: Drugs for hypertension, heart failure, angina, arrhythmias, and hyperlipidemia.
Respiratory Pharmacology: Bronchodilators, corticosteroids, antihistamines, and decongestants.
Endocrine Pharmacology: Insulin, oral hypoglycemics, thyroid medications, and corticosteroids.
Neurological and Psychiatric Pharmacology: Antiepileptics, antiparkinson agents, antidepressants,
antipsychotics, and anxiolytics.
Analgesics and Anti-inflammatory Agents: Opioids, NSAIDs, acetaminophen, and adjuvant analgesics.
Antimicrobial Pharmacology: Antibiotics, antivirals, antifungals, and antiparasitics, including resistance and
stewardship.
Chemotherapy and Immunomodulators: Antineoplastic agents, immunosuppressants, and biologic response
modifiers.
Fluid, Electrolyte, and Acid-Base Balance: IV fluids, diuretics, and electrolyte replacements.
Special Populations: Pediatric, geriatric, pregnancy/lactation considerations, and pharmacogenomics.
Updates for 2026:
- Revised to align with the 2026/2027 National Council Licensure Examination (NCLEX) test plan.
- Integrated current evidence-based practice guidelines from the American Nurses Association and specialty
organizations.
- Enhanced rationales to include critical thinking and clinical judgment cues.
- Updated drug information to reflect the latest FDA approvals and safety alerts.
- Expanded coverage of human caring frameworks in pharmacology, including Jean Watson's Theory of Human
Caring.
Abstract:
This exam preparation document for NRG 200 Pharmacology for Human Caring Nursing provides a rigorous and
comprehensive review of pharmacological principles as applied to nursing practice. It encompasses the
foundational concepts of drug therapy, including pharmacokinetics and pharmacodynamics, while emphasizing the
integration of human caring values in medication administration. The document systematically addresses major
Page 1
,drug classifications affecting the autonomic nervous system, cardiovascular, respiratory, endocrine, neurological,
and psychiatric systems, as well as analgesics, antimicrobials, chemotherapeutic agents, and fluid/electrolyte
balance. Special attention is given to vulnerable populations and the ethical-legal dimensions of pharmacotherapy.
Each of the 200 multiple-choice questions is accompanied by a correct answer and an italicized explanation that
reinforces the underlying science and clinical reasoning. This resource is designed to foster deep learning, critical
thinking, and readiness for the final examination, ultimately promoting safe and compassionate patient care.
Keywords:
Pharmacology, Human Caring, Nursing, NCLEX, Drug classifications, Pharmacokinetics, Patient-centered care,
Exam prep
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is clearly indicated,
and an explanation in italics follows, detailing the pharmacological rationale, nursing implications, and why the
other options are incorrect. This format enhances understanding and retention of key concepts.
Compliance Checklist:
Aligned with 2026/2027 NRG 200 course objectives and syllabus
Reflects the latest NCLEX-RN test plan and nursing standards
Includes 200 verified questions with accurate answers and evidence-based rationales
Covers all major content areas and drug classifications as per the curriculum
Suitable for self-assessment and comprehensive exam review
Content Area Overview:
Content Area Questions Key Topics Weight
Foundations of Pharmacology 1-20 Drug classifications, Pharmacokinetics, 10%
Pharmacodynamics, Nursing process
Human Caring in Pharmacology 21-30 Caring theories, Patient-centered care, 5%
Ethical/legal issues
Autonomic Nervous System 31-50 Adrenergic agonists/antagonists, Cholinergic 10%
Drugs agonists/antagonists
Cardiovascular Pharmacology 51-70 Antihypertensives, Heart failure drugs, 10%
Antiarrhythmics, Antianginals,
Lipid-lowering agents
Respiratory Pharmacology 71-85 Bronchodilators, Corticosteroids, 7.5%
Antihistamines, Decongestants
Endocrine Pharmacology 86-100 Insulin, Oral hypoglycemics, Thyroid 7.5%
medications, Corticosteroids
Neurological and Psychiatric 101-120 Antiepileptics, Antiparkinson agents, 10%
Pharmacology Antidepressants, Antipsychotics,
Anxiolytics
Analgesics and 121-135 Opioids, NSAIDs, Acetaminophen, 7.5%
Anti-inflammatory Agents Adjuvant analgesics
Antimicrobial Pharmacology 136-155 Antibiotics, Antivirals, Antifungals, 10%
Antiparasitics, Antimicrobial stewardship
Chemotherapy and 156-170 Antineoplastic agents, Immunosuppressants, 7.5%
Immunomodulators Biologic response modifiers
Page 2
,Fluid, Electrolyte, and 171-185 IV fluids, Diuretics, Electrolyte 7.5%
Acid-Base Balance replacements
Special Populations 186-200 Pediatric, Geriatric, Pregnancy/lactation, 7.5%
Pharmacogenomics
Page 3
, Q1. A patient with chronic kidney disease (CrCl 25 mL/min) is prescribed a
medication that is primarily excreted unchanged by the kidneys. The nurse is aware
that the half-life of this drug will be prolonged. Which pharmacokinetic parameter is
most directly affected by this renal impairment?
A. Volume of distribution
B. Clearance
C. Bioavailability
D. First-pass effect
Correct Answer: B. Clearance
Rationale: Renal impairment reduces drug clearance, leading to a prolonged half-life and
potential accumulation. Volume of distribution depends on tissue binding and body
composition, not directly on renal function. Bioavailability and first-pass effect are related
to absorption and hepatic metabolism, not renal excretion.
Why Wrong:
A - Volume of distribution is more affected by changes in body composition or protein
binding, not renal function.
C - Bioavailability is a measure of the fraction of drug that reaches systemic
circulation, influenced by absorption and hepatic metabolism.
D - First-pass effect is a hepatic phenomenon, not directly linked to renal excretion.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 4.
Q2. A nurse is caring for a patient who is taking digoxin and furosemide. The patient
reports nausea, vomiting, and visual disturbances. Which laboratory value would be
most indicative of digoxin toxicity in this context?
A. Serum potassium of 3.0 mEq/L
B. Serum magnesium of 2.0 mEq/L
C. Serum digoxin level of 0.8 ng/mL
D. Serum creatinine of 1.0 mg/dL
Correct Answer: A. Serum potassium of 3.0 mEq/L
Rationale: Hypokalemia (K+ < 3.5 mEq/L) potentiates digoxin toxicity by increasing the
binding of digoxin to Na+/K+-ATPase. Typical symptoms include GI disturbances and
visual changes. Magnesium of 2.0 mEq/L is normal, digoxin level of 0.8 is therapeutic, and
creatinine of 1.0 is normal.
Why Wrong:
B - Normal magnesium levels do not precipitate digoxin toxicity.
C - A digoxin level of 0.8 ng/mL is within the therapeutic range (0.5-2.0 ng/mL).
D - Normal renal function does not directly cause digoxin toxicity.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 30.
Page 4
